A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 401–500 of 2,275
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Hubackova, S., Davidova, E., Rohlenova, K., Stursa, J., Werner, L., Andera, L., Dong, L., Terp, M. G., Hodny, Z., Ditzel, H. J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0118-3 · Cited by 101
“These factors not only contribute to the maintenance of senescence via a self-amplifying feedback loop, but can also induce senescence in healthy cells in a paracrine manner [8], for example due to increase in reactive oxygen species”
BackgroundThe role of myeloid-derived suppressor cells (MDSC) in the inflammaging process
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.09.001 · Cited by 107
Marino, F., Scalise, M., Salerno, N., Salerno, L., Molinaro, C., Cappetta, D., Torella, M., Greco, M., FOTI, D. P., Sasso, F. C., et al. (2022) · Diabetes · doi:10.2337/db21-0536 · Cited by 105
Radiation induces senescence and a bystander effect through metabolic alterations
Liao, E.-C., Hsu, Y.-T., Chuah, Q.-Y., Lee, Y. J., Hu, J.-Y., Huang, T.-C., Yang, P., & Chiu, S.-J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.220 · Cited by 117
“paracrine senescence.(45) Our previous study also demonstrated that the senescent MDA-MB-231-2A cells release VEGF, MCP-1 and MIP-3a.”
BackgroundHepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100
The RNA-binding protein YBX1 regulates epidermal progenitors at a posttranscriptional level
Kwon, E., Todorova, K., Wang, J., Horos, R., Lee, K. K., Neel, V. A., Negri, G. L., Sorensen, P. H., Lee, S. W., Hentze, M. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04092-0 · Cited by 99
Molecular pathways of senescence regulate placental structure and function
Gal, H., Lysenko, M., Stroganov, S., Vadai, E., Youssef, S. A., Tzadikevitch‐Geffen, K., Rotkopf, R., Biron‐Shental, T., de Bruin, A., Neeman, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100849 · Cited by 99
“…SASP can, in a cell non-autonomous manner, modulate the senescent cell microenvironment, promote the interaction with the immune system, and reinforce growth arrest of the adjacent senescent cells (Acosta et al , 2008, 2013; Krizhanovsky et al , 2008; Kuilman et al , 2008; Lujambio et al , 2013).”
Cellular senescence and the skeleton: pathophysiology and therapeutic implications
Khosla, S., Farr, J. N., & Monroe, D. G. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154888 · Cited by 100
Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype
Jakhar, R., & Crasta, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102547 · Cited by 98
“While SASP factors can exert tumor suppression by reinforcing senescence (autocrine) or inducing senescence in neighbouring cells (paracrine) [86,90], these factors can also promote tumorigenesis, via a cell non-autonomous manner [89], in neighbouring non-senescent cells.”
BackgroundMatsudaira, T., Nakano, S., Konishi, Y., Kawamoto, S., Uemura, K., Kondo, T., Sakurai, K., Ozawa, T., Hikida, T., Komine, O., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05027-2 · Cited by 98
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Self-citationEmerging role of aging in the progression of NAFLD to HCC
He, Y., Su, Y., Duan, C., Wang, S., He, W., Zhang, Y., An, X., & He, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101833 · Cited by 97
Loss of MT1-MMP causes cell senescence and nuclear defects which can be reversed by retinoic acid
Gutiérrez‐Fernández, A., Soria‐Valles, C., Osorio, F. G., Gutiérrez‐Abril, J., Garabaya, C., Aguirre, A., Fueyo, A., Fernández‐García, M. S., Puente, X. S., & López‐Otín, C. (2015) · The EMBO Journal · doi:10.15252/embj.201490594 · Cited by 96
“Furthermore, and in agreement with recent data showing that the TGF-b 1 pathway mediates paracrine senescence and influences senescence in vivo (Acosta et al , 2013), we observed that Mmp14 -deficient mice show a significant increase in TGF-b 1 levels (Supplementary Fig S3D).”
Aguado, J., Chaggar, H. K., Gómez‐Inclán, C., Shaker, M. R., Leeson, H. C., Mackay‐Sim, A., & Wolvetang, E. J. (2021) · Aging Cell · doi:10.1111/acel.13468 · Cited by 92
“…SA- β- gal experiments, A- T BOs displayed a significantly higher secretion of SASP proteins compared to their WT counterparts (Figure 3a), a result indicative of a putative role of SASP factors in inducing paracrine senescence, as previously described (Acosta et al., 2013; Nelson et al., 2012).”
ResultMitochondrial redox system, dynamics, and dysfunction in lung inflammaging and COPD
Lerner, C. A., Sundar, I. K., & Rahman, I. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.026 · Cited by 108
“…regarded as resistant to apoptotic signals, this falls in line with data showing IL-1β stimulated PBMCs resist apoptosis (Mangan et al., 1991) while IL-1β activity (in conjunction with IL-1α) has a role in inducing senescence in target human fibroblasts in a paracrine manner (Acosta et al., 2013).”
BackgroundMeijles, D. N., Sahoo, S., Al Ghouleh, I., Amaral, J. H., Bienes-Martinez, R., Knupp, H. E., Attaran, S., Sembrat, J. C., Nouraie, S. M., Rojas, M. M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaj1784 · Cited by 96
“In addition to cell cycle arrest, senescent cells accumulate senescence markers, including senescence-associated β-galactosidase (SA-β-Gal), and secrete vasoactive factors (11).”
BackgroundGeneration and Release of Mitochondrial-Derived Vesicles in Health, Aging and Disease
Picca, A., Guerra, F., Calvani, R., Coelho-Junior, H. J., Bossola, M., Landi, F., Bernabei, R., Bucci, C., & Marzetti, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051440 · Cited by 95
“The release of SASP factors perturbs the local microenvironment through autocrine and paracrine actions aimed at preventing the growth of damaged cells while recruiting immune cells and promoting tissue repair [106,107].”
BackgroundFrom AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
Wang, Z., & Zhang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810880 · Cited by 118
Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction
Xu, M., Tchkonia, T., & Kirkland, J. L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.015 · Cited by 99
“Senescent cells appear to be able to spread senescence to nearby cells (18, 19).”
Malaise, O., Tachikart, Y., Constantinides, M., Mumme, M., Ferreira-Lopez, R., Noack, S., Krettek, C., Noël, D., Wang, J., Jorgensen, C., et al. (2019) · Aging · doi:10.18632/aging.102379 · Cited by 95
“…in a mouse model [22]), CHI3L1/YKL-40 and IGFBP-3 (two OA synovial fluid biomarkers that correlate with disease progression [23, 24]), and IL-8 and CCL2/MCP1 (two inflammatory cytokines that trigger in vitro senescence onset and that are usual component of the SASP [25, 26]) (Figure 2I).”
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
Rayego‐Mateos, S., Campillo, S., Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Márquez‐Expósito, L., Goldschmeding, R., Rodríguez-Puyol, D., Calleros, L., & Ruiz‐Ortega, M. (2021) · Clinical Science · doi:10.1042/cs20201016 · Cited by 108
Cellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
“The senescent secretome, regulated by pathways associated with IL1beta (Acosta et al. 2013), HMGB1 (Davalos et al. 2013), p38 (Freund et al. 2011) and NFkB (Chien et al. 2011) appears to be similar to a wound healing response, likely facilitating in immunosurveillance of senescent cells.”
BackgroundYoung, H. L., Rowling, E. J., Bugatti, M., Giurisato, E., Luheshi, N., Arozarena, I., Acosta, J.-C., Kamarashev, J., Frederick, D. T., Cooper, Z. A., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160855 · Cited by 95
“…was quantified by measuring the absorbance of the solubilized dye (in 2% SDS in PBS) at an optical density of 595 nm. cytokine array IMR-90 human diploid fibroblasts were transduced with empty MSCV-puro retroviral vector or vector encoding IL-1A as previously described (Acosta et al., 2013).”
MethodSelf-citationCellular senescence as a potential mediator of COVID‐19 severity in the elderly
Nehme, J., Borghesan, M., Mackedenski, S., Bird, T. G., & Demaria, M. (2020) · Aging Cell · doi:10.1111/acel.13237 · Cited by 94
“Many of these factors have the potential to induce “paracrine” senescence via prolonged cytokine signaling (Acosta et al., 2013; Kandhaya-Pillai et al., 2017; Kim et al., 2009) (Figure 1).”
BackgroundThe role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Liu, H., Zhao, H., & Sun, Y. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.004 · Cited by 109
Herbstein, F., Sapochnik, M., Attorresi, A. I., Pollak, C., Senin, S. A., Gonilski‐Pacin, D., del Giudice, N. C., Fiz, M., Elguero, B., Fuertes, M., et al. (2024) · Aging Cell · doi:10.1111/acel.14258 · Cited by 121
“They can transmit cellular senescence to normal neighboring cells in a paracrine manner (Acosta et al., 2013 ).”
BackgroundCellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
“Interestingly, in a murine rectal cancer and patient-derived tumor organoids model, IL-1α was found to predispose inflammatory CAFs to p53-mediated TIS upon irradiation, which in turn resulted in chemoradiotherapy resistance and disease progression through the secretion of cytokines and extracellular matrix constituen…”
BackgroundInfluentialHubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 105
The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes
Tapia, V. S., Daniels, M. J. D., Palazón‐Riquelme, P., Dewhurst, M. R., Luheshi, N., Rivers‐Auty, J., Green, J., Redondo‐Castro, E., Kaldis, P., López‐Castejón, G., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008009 · Cited by 97
“A defining feature of cellular senescence is the expression of IL-1 , which is critical for the development of the SASP and in some cases can drive senescence (34), whereas in other cases, blockade of IL-1 reduces the SASP, but the cell still senesces (35, 36).”
BackgroundAutophagy, Cellular Aging and Age-related Human Diseases
Cheon, S. Y., Kim, H. J., Rubinsztein, D. C., & Lee, J. E. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.6.643 · Cited by 104
“Through paracrine (non-cell-autonomous) or autocrine (cell-autonomous) mechanisms, SASP components from senescent cells, can reinforce cellular senescence and are involved in the progression of aging [7, 91, 95].”
BackgroundNovel insights from a multiomics dissection of the Hayflick limit
Chan, M., Yuan, H., Soifer, I., Maile, T. M., Wang, R. Y., Ireland, A., O'Brien, J. J., Goudeau, J., Chan, L. J., Vijay, T., et al. (2022) · eLife · doi:10.7554/elife.70283 · Cited by 99
“The SASP has been shown to play a role in paracrine signaling whereby senescent cells can promote local wound healing and/or drive healthy neighboring cells into senescence ( Acosta et al., 2013 ; Coppé et al., 2006 ; Demaria et al., 2014 ; Coppé et al., 2008 ).”
Age-related diseases as vicious cycles
Belikov, A. V. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.002 · Cited by 90
The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
Can blocking inflammation enhance immunity during aging?
Chambers, E. S., & Akbar, A. N. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.016 · Cited by 92
“Multiple components of the SASP including CCL2, Transforming growth factor (TGFβ) and IL-1α have the ability to drive senescence in a paracrine manner in nearby non-senescent cells, thus overall increasing the number of senescent cells (60).”
BackgroundDePianto, D. J., Heiden, J. A. V., Morshead, K. B., Sun, K.-H., Modrusan, Z., Teng, G., Wolters, P. J., & Arron, J. R. (2021) · JCI Insight · doi:10.1172/jci.insight.143626 · Cited by 92
“We observed enhanced gene expression of SASP factors CSF2 , IL6 , and CXCL8 in senescent SAEC cultures compared with controls (Figure 2F) (14).”
InfluentialKolodkin-Gal, D., Roitman, L., Ovadya, Y., Azazmeh, N., Assouline, B., Schlesinger, Y., Kalifa, R., Horwitz, S., Khalatnik, Y., Hochner-Ger, A., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-321112 · Cited by 92
Cellular senescence of renal tubular epithelial cells in acute kidney injury
Chen, J., Zhang, H., Yi, X., Dou, Q., Yang, X., He, Y., Chen, J., & Chen, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01831-9 · Cited by 110
“Tumor-induced senescence in liver cells is characterized by CCL-2, inducing immune surveillance effects [15].”
BackgroundSASP regulation by noncoding RNA
Panda, A. C., Abdelmohsen, K., & Gorospe, M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.05.004 · Cited by 86
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Kricker, J. A., Page, C. P., Gardarsson, F. R., Baldursson, Ó., Guðjónsson, Þ., & Parnham, M. J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000300 · Cited by 109
“SASP and inflammasomes are closely linked, as SASP is controlled by inflammasome-mediated IL-1 signaling (Acosta et al., 2013).”
BackgroundPrattichizzo, F., Giuliani, A., Recchioni, R., Bonafè, M., Marcheselli, F., De Carolis, S., Campanati, A., Giuliodori, K., Rippo, M. R., Brugè, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7858 · Cited by 90
“However, the present findings are in line with earlier reports [9, 17] that it is possible to dissociate the SASP from senescence, and encourage the search for substances, synthetic or natural, that not only suppress but also restrain the SASP.”
BackgroundResultInfluentialCancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 90
Dissecting primary and secondary senescence to enable new senotherapeutic strategies
Admasu, T. D., Rae, M. J., & Stolzing, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101412 · Cited by 103
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon, J., Petit, C., Moreau, M., Toutain, B., Henry, C., Roché, H., Bonichon-Lamichhane, N., Salmon, J. P., Lemonnier, J., Campone, M., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1406-7 · Cited by 90
Nuclear pore density controls heterochromatin reorganization during senescence
Boumendil, C., Hari, P., Olsen, K. C. F., Acosta, J. C., & Bickmore, W. A. (2019) · Genes & Development · doi:10.1101/gad.321117.118 · Cited by 89
Self-citationTargeting the SASP to combat ageing: Mitochondria as possible intracellular allies?
Birch, J., & Passos, J. F. (2017) · BioEssays · doi:10.1002/bies.201600235 · Cited by 89
“The SASP has both autocrine and paracrine effects, reinforcing senescence and inducing senescence in nearby cells [20, 21].”
BackgroundAging and Senescence of Dental Pulp and Hard Tissues of the Tooth
Maeda, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.605996 · Cited by 97
Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases
Tavenier, J., Nehlin, J. O., Houlind, M. B., Rasmussen, L. J., Tchkonia, T., Kirkland, J. L., Andersen, O., & Rasmussen, L. J. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111995 · Cited by 111
“…may trigger inflammation, impair tissue homeostasis and repair, and induce cell death or senescence in other cells both locally and systemically (Acosta et al., 2013; Copp ´ e et al., 2010; da Silva et al., 2019; Di Micco et al., 2021; Gnani et al., 2019; Khoslo et al., 2020; Nelson et al.,…”
Molecular and genetic insights into human ovarian aging from single-nuclei multi-omics analyses
Jin, C., Wang, X., Yang, J., Kim, S.-S., Hudgins, A. D., Gamliel, A., Pei, M., Contreras, D., Devos, M., Guo, Q., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00762-5 · Cited by 130
“In our analyses, CDKN1A + cells showed upregulation of several SASP genes across multiple cell types, although this was not consistent across all cell types, aligning with a previous report of cell-type-specific SASP expression 48 .”
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Bae, Y.-U., Son, Y., Kim, C.-H., Kim, K. S., Hyun, S. H., Woo, H. G., Jee, B. A., Choi, J.-H., Sung, H.-K., Choi, H.-C., et al. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly208 · Cited by 89
Functional heterogeneity in senescence
Kirschner, K., Rattanavirotkul, N., Quince, M. F., & Chandra, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190109 · Cited by 89
Suppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84
“translationally upregulated and secreted into the surrounding microenvironment by senescent cells [14-18].”
BackgroundInterventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A., Mladenovic Djordjevic, A., Lopez-Contreras, A., Henriques, C. M., Selman, C., Ferreiro, E., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87
Shen, W., Liu, L., & Zeng, S. (2018) · Cancer translational medicine · doi:10.4103/ctm.ctm_22_18 · Cited by 98
De Carvalho, F. G., Justice, J. N., Freitas, E. C. D., Kershaw, E. E., & Sparks, L. M. (2019) · Nutrients · doi:10.3390/nu11112553 · Cited by 87
The redox-senescence axis and its therapeutic targeting
Ngoi, N. Y., Liew, A. Q., Chong, S. J. F., Davids, M. S., Clement, M.-V., & Pervaiz, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102032 · Cited by 88
Zhang, L., Zhao, J., Mu, X., McGowan, S. J., Angelini, L., O'Kelly, R. D., Yousefzadeh, M. J., Sakamoto, A., Aversa, Z., LeBrasseur, N. K., et al. (2021) · Aging Cell · doi:10.1111/acel.13486 · Cited by 89
“The elevated production of SASPs can further enhance cellular senescence in cell autonomous and/or cell non- autonomous pathways, contributing to many pathological disorders associated with aging (Acosta et al., 2013; Chien et al., 2011; Coppe et al., 2010; Nelson et al., 2012).”
BackgroundMolecular Mechanisms of Kidney Injury and Repair
Rayego‐Mateos, S., Márquez‐Expósito, L., Rodrigues‐Díez, R., Sanz, A. B., Guiteras, R., Doladé, N. G., Rubio-Soto, I., Manonelles, A., Codina, S., Ortíz, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031542 · Cited by 103
“By releasing these factors, senescent cells can exert deleterious pro-inflammatory and pro-fibrotic actions [54,63,66].”
BackgroundNon-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
“org May 2018 | Volume 8 | Article 164 only confined solely to genes involved in cell cycle regulation but also include increased expression of a spectrum of secreted proteins (10, 11).”
BackgroundHIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 100
“, 2009) and paracrine senescence by induction of senescence in healthy neighboring cells (Acosta et al., 2013).”
Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2018) · Biogerontology · doi:10.1007/s10522-018-9762-8 · Cited by 84
Detection of senescence using machine learning algorithms based on nuclear features
Duran, I., Pombo, J., Sun, B., Gallage, S., Kudo, H., McHugh, D., Bousset, L., Barragan Avila, J. E., Forlano, R., Manousou, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45421-w · Cited by 85
Self-citationBlocking negative effects of senescence in human skin fibroblasts with a plant extract
Lämmermann, I., Terlecki-Zaniewicz, L., Weinmüllner, R., Schosserer, M., Dellago, H., de Matos Branco, A. D., Autheried, D., Sevcnikar, B., Kleissl, L., Berlin, I., et al. (2018) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-018-0023-5 · Cited by 84
Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
Vernot, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00063 · Cited by 86
Jiang, W., Liu, H., Wan, R., Wu, Y., Shi, Z., & Huang, W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101315 · Cited by 92
mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
Cayo, A., Segovia, R., Venturini, W., Moore-Carrasco, R., Valenzuela, C., & Brown, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158149 · Cited by 93
“As expected, this “senescence-associated secretory phenotype (SASP)” greatly expands the effects of senescent cells arising in complex tissues [12,42,43]: while some SASP factors perpetuate, or even promote, senescence [44], others can stimulate proliferation or enhance the migration of non-senescent neighbor cells [1…”
BackgroundPotential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging
Han, X., Lei, Q., Xie, J., Liu, H., Li, J., Zhang, X., Zhang, T., & Gou, X. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac097 · Cited by 112
Hussong, S. A., Banh, A. Q., Skike, C. E. V., Dorigatti, A. O., Hernandez, S. F., Hart, M. J., Ferrán, B., Makhlouf, H., Gaczynska, M. E., Osmulski, P. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37840-y · Cited by 92
Exosome-based immunomodulation during aging: A nano-perspective on inflamm-aging
Prattichizzo, F., Micolucci, L., Cricca, M., De Carolis, S., Mensà, E., Ceriello, A., Procopio, A. D., Bonafè, M., & Olivieri, F. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.02.008 · Cited by 85
Deryabin, P. I., Griukova, A., Nikolsky, N. N., & Borodkina, A. V. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03374-0 · Cited by 96
“Moreover, factors secreted by senescent cells via the auto/paracrine pathway are able to initiate cell cycle arrest and proliferation loss in the neighboring cells, accelerating propagation of senescence within cell population and thus contributing to chronic inflammation and tissue dysfunction [27, 30, 31].”
BackgroundSenescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84
“This model has been extensively validated, in both primary mouse microglia and human microglia, demonstrating significant retention of iron, morphological alterations, as well as increased release of ROS and cytokines (including IL-1β, TNF-α, and Interferon γ), suggestive of SASP or a similar phenotype.”
BackgroundInfluentialCellular senescence: Implications for metabolic disease
Schafer, M. J., Miller, J. D., & LeBrasseur, N. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.047 · Cited by 83
“Hepatic studies have also supported the hypothesis that senescence may be paracrinely propagated [66,71,72].”
BackgroundEmerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
Alqahtani, S., Alqahtani, T., Venkatesan, K., Sivadasan, D., Ahmed, R., Sirag, N., Elfadil, H., Mohamed, H. A., A, H., Ahmed, R. E., et al. (2025) · Cells · doi:10.3390/cells14080608 · Cited by 112
“, epithelial cells, and hepatic stellate cells [9,56] (Figure 3).”
Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Byun, H.-O., Lee, Y.-K., Kim, J.-M., & Yoon, G. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.122 · Cited by 83
“such as HGF, FGF, TGF1 and GM-CSF, has also been reported in various types of senescent cells (54, 74).”
BackgroundMitochondria and cellular senescence: Implications for musculoskeletal ageing
Habiballa, L., Salmonowicz, H., & Passos, J. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.417 · Cited by 82
Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review
Amaya-Montoya, M., Pérez-Londoño, A., Guatibonza-García, V., Vargas-Villanueva, A., & Mendivil, C. O. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01287-0 · Cited by 82
Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases
Yang, B., Lin, Y., Huang, Y., Shen, Y.-Q., & Chen, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103032 · Cited by 99
“Furthermore, ROS play a crucial role in maintaining cellular senescence by sustaining the senescence-associated secretory phenotype (SASP), which encompasses pro-inflammatory cytokines, chemokines, growth factors, and proteases that impact the surrounding tissue microenvironment [6,7].”
BackgroundZhang, F., Guo, J., Yu, S., Zheng, Y., Duan, M., Zhao, L., Wang, Y., Yang, Z., & Jiang, X. (2024) · 癌症:英文版 · doi:10.1002/cac2.12591 · Cited by 112
Numb is required to prevent p53-dependent senescence following skeletal muscle injury
Le Roux, I., Konge, J., Le Cam, L., Flamant, P., & Tajbakhsh, S. (2015) · Nature Communications · doi:10.1038/ncomms9528 · Cited by 81
Senescent endothelial cells: Potential modulators of immunosenescence and ageing
Pantsulaia, I., Ciszewski, W. M., & Niewiarowska, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.011 · Cited by 84
Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00178 · Cited by 79
“These are capable of affecting neighboring cells and converting them to senescence in a paracrine manner (Kuilman and Peeper, 2009; Acosta et al., 2013).”
BackgroundResultCellular senescence links mitochondria-ER contacts and aging
Ziegler, D. V., Martin, N., & Bernard, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02840-5 · Cited by 100
Preininger, M. K., & Kaufer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116217 · Cited by 92
DNA Damage and Repair in Vascular Disease
Uryga, A., Gray, K., & Bennett, M. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105127 · Cited by 81
(2019) · doi:10.1101/2019.12.19.882225 · Cited by 81
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
“Importantly, these inflammatory cytokines in turn reinforce the activity of those transcription factors through a positive feedback loop; thus, the signaling is locally amplified (Kuilman et al. 2008; Orjalo et al. 2009; Acosta et al. 2013; Pérez-Mancera et al. 2014).”
BackgroundKolesnichenko, M., Mikuda, N., Höpken, U. E., Kärgel, E., Uyar, B., Tufan, A. B., Milanovic, M., Sun, W., Krahn, I., Schleich, K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2019104296 · Cited by 81
“…however, comprises factors that may instigate oncogenic transformation, cell migration, and cancer stemness (Acosta et al , 2008; Reimann et al , 2010; Chien et al , 2011; Freund et al , 2011; Jing et al , 2011; Acosta et al , 2013; Salama et al , 2014; Hoare et al , 2016; Milanovic et al , 2018).”
Consequences of mitotic slippage for antimicrotubule drug therapy
Cheng, B., & Crasta, K. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0147 · Cited by 93
Han, X., Chen, H., Gong, H., Tang, X., Huang, N., Xu, W., Tai, H., Zhang, G., Zhao, T., Gong, C., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010734 · Cited by 80
“Accumulating evidence indicates that SASP factors exert a non-cell-autonomous function and can alter the behavior of neighboring cells or play cell-autonomous roles and reinforce the senescence state (15, 20).”
BackgroundMazzoni, M., Mauro, G., Erreni, M., Romeo, P., Minna, E., Vizioli, M. G., Belgiovine, C., Rizzetti, M. G., Pagliardini, S., Avigni, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1198-8 · Cited by 91
Evidence of sex differences in cellular senescence
Ng, M., & Hazrati, L.-N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.014 · Cited by 78
Hwang, A. B., & Brack, A. S. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.08.008 · Cited by 89
Cellular senescence and the host immune system in aging and age-related disorders
Giannoula, Y., Kroemer, G., & Pietrocola, F. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.02.001 · Cited by 79
“[57] Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al.”
BackgroundMechanisms of MicroRNAs in Atherosclerosis
Schober, A., & Weber, C. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044135 · Cited by 81
Current perspectives on the cellular and molecular features of epigenetic ageing
Raj, K., & Horvath, S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220918329 · Cited by 77
Hu, Q., Peng, J., Jiang, L., Li, W., Su, Q., Zhang, J., Li, H., Song, M., Cheng, B., Xia, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03126-0 · Cited by 90
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.